Publication | Closed Access

Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen

Breast OncologyMedicineHormonal ReceptorPharmacologyGynecologyOestrogen Receptor αAromataseBreast CancerOncologyRadiation OncologyMammary Gland DevelopmentEndocrine-related Cancer